Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative bioavailability and pharmacokinetics study of ginsenoside Compound K solubilizing tablets in healthy Chinese adults
ChiCTR-TTRCC-14004177Phase 4Completed
- Sponsor
- Pharmacogenetics Research Institute, Xiangya Hospital, Central South University
- Start
- Feb 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ginsenoside compound k (3 arms), sponsored by Pharmacogenetics Research Institute, Xiangya Hospital, Central South University. Primary endpoints: Relative bioavailability and Pharmacokinetic parameters. Started Feb 2014; status: completed.
02
Drugs
ginsenoside compound k
Beyond the preview
Go deeper on ChiCTR-TTRCC-14004177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TTRCC-14004177.